O. Gadeberg

发表

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.

L. Sehn, A. Zelenetz, J. Friedberg, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group.

F. d'Amore, A. O. Gang, B. Pedersen, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Follicular lymphoma in young patients (>50 yrs): A population-based analysis of the Danish lymphoma registry

M. Møller, M. Hansen, Torben M. Andersen, 2008 .

In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes

I. Orskov, O. Gadeberg, 1984, Infection and immunity.

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1–2 study

B. Coiffier, S. Leprêtre, M. V. van Oers, 2010, British journal of haematology.

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study.

B. Coiffier, S. Leprêtre, M. V. van Oers, 2008, Blood.

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

J. Delabie, H. Holte, F. d'Amore, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cigarette Smoking and Risk of Non-Hodgkin's Lymphoma—A Population-Based Case-Control Study

H. Adami, M. Melbye, G. Roos, 2005, Cancer Epidemiology Biomarkers & Prevention.

Branhamella catarrhalis: significance in pulmonary infections and bacteriological features.

B. Bruun, O. Gadeberg, J. J. Christensen, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

monoclonal antibody in relapsed or refractory follicular lymphoma: First clinical use of ofatumumab, a novel fully human anti-CD20

P. Sonneveld, M. Pfreundschuh, T. Robak, 2013 .

Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma

M. Czuczman, G. Hess, S. Lisby, 2012, British journal of haematology.

Combination of two anti‐CD5 monoclonal antibodies synergistically induces complement‐dependent cytotoxicity of chronic lymphocytic leukaemia cells

D. Frank, C. Geisler, J. Jurlander, 2013, British journal of haematology.

In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Correlation with size of alpha-hemolysin production.

S. Larsen, O. Gadeberg, 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

In vitro cytotoxic effect of α‐hemolytic Escherichia coli on human blood granulocytes

S. Larsen, O. Gadeberg, 1988 .

Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro

I. Orskov, O. Gadeberg, J. Rhodes, 1983, Infection and immunity.

In vitro Cytotoxic Effect of α-Hemolytic Escherichia coli on Human Blood Granulocytes Inhibition by α-Hemolysin Antibody

B. Mansa, O. Gadeberg, 1990 .

In vitro cytotoxic effect of alpha-hemolytic and nonhemolytic Escherichia coli on human blood granulocytes and monocytes.

O. Gadeberg, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.

A. Hagenbeek, P. Sonneveld, J. Radford, 2008, Blood.

Safety and efﬁcacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

B. Coiffier, S. Leprêtre, T. Robak, 2008 .

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

K. Young, Z. Xu-Monette, O. Nielsen, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of various immunosuppressive agents on mouse peritoneal macrophages and on the in vitro phagocytosis of Escherichia coli O4:K3:H5 and degradation of 125I-labelled HSA-antibody complexes by these cells.

S. Larsen, O. Gadeberg, J. Rhodes, 1975, Immunology.

Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.

O. Gadeberg, A. Sørensen, L. Friis, 2010, Cancer genetics and cytogenetics.

Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study

K. Thorling, J. Lamvik, O. Bjerrum, 1993, European journal of haematology.

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

J. Delabie, H. Holte, F. d'Amore, 2010 .

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

J. Delabie, H. Holte, F. d'Amore, 2006 .

Morphological study of the in vitro cytotoxic effect of alpha-hemolytic E. coli bacteria and culture supernatants on human blood granulocytes and monocytes.

J. Blom, O. Gadeberg, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

[Neonatal conjunctivitis after the abolition of compulsory Credé prophylaxis].

S. Larsen, H. J. Kolmos, O. Gadeberg, 1991, Ugeskrift for laeger.

Cytogenetic findings in adult de novo acute myeloid leukaemia. A population‐based study of 303/337 patients

K. Schmidt, N. T. Pedersen, O. Gadeberg, 2003, British journal of haematology.

Isolation of human peripheral blood monocytes: a comparative methodological study.

S O Larsen, J M Rhodes, S. Larsen, 1979, Journal of immunological methods.

Neisseria meningitidis: Occurrence in non‐pneumonic pulmonary infections

B. Bruun, O. Gadeberg, J. J. Christensen, 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Phase I/II study of SPC2996, an RNA antagonist of Bcl-2, in patients with advanced chronic lymphocytic leukemia (CLL)

B. Coiffier, J. Radford, H. Tilly, 2007 .

Role of α-Hemolysin for the in vitro Phagocytosis and Intracellular Killing of Escherichia coli

J. Hacker, I. Ørskov, O. Gadeberg, 1989 .

Adenosine deaminase, purine nucleoside phosphorylase and 5'-nucleotidase activities in infectious mononucleosis.

P. Nygaard, J. Cohn, V. Faber, 1984, Advances in experimental medicine and biology.

Role of alpha-hemolysin for the in vitro phagocytosis and intracellular killing of Escherichia coli.

J. Hacker, I. Orskov, O. Gadeberg, 1989, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group.

F. d'Amore, B. Pedersen, A. Bukh, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.